Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
Effect of antipsychotics on brain insulin action and glucose homeostasis in healthy participants
FY 2019-20
Summary
"Schizophrenia is a severe brain disorder that affects approximately 1 in every 100 Canadians. It is characterized by changes in thought and behaviour patterns as well as cognitive and emotional dysfunction which work together to impair daily functioning. Currently, antipsychotics are the most common and effective treatment for schizophrenia, however, their use is associated with significant weight gain and other metabolic side effects such as increased levels of sugar (glucose) in the bloodstream. These side effects promote the development of obesity, type 2 diabetes, and heart disease which decrease patients' quality of life and overall lifespan. Although these changes are well-documented, scientists are still working towards understanding why and how they occur. Recent research at both the cellular level and in rodents suggests that antipsychotics may lead to metabolic dysfunction by affecting how the brain responds to the hormone insulin which helps regulate glucose levels throughout the body. The purpose of this study is to determine if this relationship also extends to humans. Specifically, this study will test if a single dose of the antipsychotic olanzapine can directly decrease the brain's response to insulin in healthy participants, thus promoting glucose production and release by the liver. If so, it would suggest that the metabolic effects of antipsychotics are due to brain insulin resistance. This finding could have implications for the development of treatments such as insulin sensitizers that could prevent or reverse the negative side effects of antipsychotics. This would have a positive impact on patients, their loved ones, and their community as a whole by increasing treatment compliance and thus patient well-being and integration into society."
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
429038
Name
Smith Emily C
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Effect of antipsychotics on brain insulin action and glucose homeostasis in healthy participants
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Antipsychotics; Brain Insulin; Glucose Regulation; Insulin Resistance; Intranasal Insulin; Metabolic Syndrome; Schizophrenia; Therapeutic Intervention
Abstract
"Schizophrenia is a severe brain disorder that affects approximately 1 in every 100 Canadians. It is characterized by changes in thought and behaviour patterns as well as cognitive and emotional dysfunction which work together to impair daily functioning. Currently, antipsychotics are the most common and effective treatment for schizophrenia, however, their use is associated with significant weight gain and other metabolic side effects such as increased levels of sugar (glucose) in the bloodstream. These side effects promote the development of obesity, type 2 diabetes, and heart disease which decrease patients' quality of life and overall lifespan. Although these changes are well-documented, scientists are still working towards understanding why and how they occur. Recent research at both the cellular level and in rodents suggests that antipsychotics may lead to metabolic dysfunction by affecting how the brain responds to the hormone insulin which helps regulate glucose levels throughout the body. The purpose of this study is to determine if this relationship also extends to humans. Specifically, this study will test if a single dose of the antipsychotic olanzapine can directly decrease the brain's response to insulin in healthy participants, thus promoting glucose production and release by the liver. If so, it would suggest that the metabolic effects of antipsychotics are due to brain insulin resistance. This finding could have implications for the development of treatments such as insulin sensitizers that could prevent or reverse the negative side effects of antipsychotics. This would have a positive impact on patients, their loved ones, and their community as a whole by increasing treatment compliance and thus patient well-being and integration into society."
Competitiondate
201912
Approvedterm2
1 yr 0 mth
Pinamesdelim
Smith, Emily C
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~